Crossmark

NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin

Crossref DOI link: https://doi.org/10.1038/s41420-018-0060-7

Published Online: 2018-05-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsu, Cheng-Ming

Lin, Pai-Mei

Tsai, Yao-Te

Tsai, Ming-Shao

Tseng, Chun-Han

Lin, Sheng-Fung

Yang, Ming-Yu
License Information

Text and Data Mining valid from 2018-05-10

Version of Record valid from 2018-05-10
More Information

Article History

Received: 9 February 2018

Revised: 2 April 2018

Accepted: 9 April 2018

First Online: 10 May 2018

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below